Oil prices fall as inventory report reflects demand weakness
By Laura Sanicola NEW YORK (Reuters) - Oil prices dropped Wednesday after U.S.
By Laura Sanicola
NEW YORK (Reuters) - Oil prices dropped Wednesday after U.S. inventory figures showed demand weakening for refined products as global COVID-19 cases spiked.
Brent crude futures were at $41.64 a barrel, down $1.51, or 3.5%, as of 12:48 p.m. ET (1648 GMT). U.S. West Texas Intermediate (WTI) crude futures dropped $1.72, or 4.1%, to $39.98. Both benchmarks rose in the previous session.
Crude inventories fell by 1 million barrels in the week to Oct. 16 to 488.1 million barrels, while gasoline stocks rose in another weak showing for fuel demand.
Overall product supplied, a proxy for demand, remained down 13% on the year and over the past four weeks when compared with the year-ago period.
"The market is seriously grappling with demand in the wake of a continued rise in COVID-19 cases," said Tony Headrick, energy markets analyst at CHS Hedging.
Adding to pressure, worldwide COVID-19 cases crossed 40 million on Tuesday, with some parts of Europe imposing renewed lockdown measures.
"Brent is particularly exposed to European regions which are undergoing new lockdowns," Headrick said,
On the supply side, Russia's energy minister said on Tuesday it was too early to discuss the future of global oil production curbs beyond December, less than a week after saying plans to scale back existing output restrictions should proceed.
Earlier this year the Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia - together known as OPEC+ - agreed to trim production cuts in January from a current 7.7 million barrels per day (bpd) to roughly 5.7 million bpd.
At the same time, OPEC member Libya, which is exempt from the cuts, is also ramping up production after armed conflict shut almost all its output in January. Production has recovered to about 500,000 bpd with Tripoli expecting that figure to double by year-end.
The battle over a hefty, new U.S. coronavirus aid bill was set to spill into Wednesday as the White House and Democrats try to strike a deal before the Nov. 3 presidential and congressional elections, now with the encouragement of President Donald Trump.
(Additional reporting by Julia Payne in London, Yuka Obayashi in Tokyo; Editing by David Gregorio, Louise Heavens and Giles Elgood)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days. The final analysis comes just one week after initial results from the trial showed the vaccine was more than 90% effective.
By Shaina Ahluwalia (Reuters) - Total coronavirus cases in Africa surpassed the 2 million mark on Wednesday despite the slow addition of reported infections compared to other regions around the world.
(Reuters) - Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.34 million lives worldwide: Who is furthest along?